У нас вы можете посмотреть бесплатно TCT 25: ENCIRCLE Trial Insights with Dr Daniels & Dr Hamid или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Dr Nadira Hamid (Minneapolis Heart Institute, US), interventional echocardiographer sits down with ENCIRCLE's (Edwards Lifesciences) Principal Investigator, Dr David V Daniels (California Pacific Medical Center, US) to have a deep dive into the latest data with SAPIEN M3. The ENCIRCLE trial (NCT04153292) is a prospective, multicentre, single-arm study evaluating the safety and effectiveness of the SAPIEN M3 transcatheter mitral valve replacement (TMVR) system in patients with symptomatic ≥3+ mitral regurgitation who are unsuitable for surgery or other transcatheter options. With 900 patients enrolled, the study assesses outcomes following transseptal TMVR using the dedicated SAPIEN M3 valve and dock system, offering new insights into a potential treatment pathway for high-risk MR patients. The composite primary endpoint (all-cause mortality or HF rehospitalization at 1 year) was 25.2% versus the pre-specified 45% performance goal; all-cause mortality and HF rehospitalization were 13.9% and 16.7%, respectively. Over 95% achieved MR ≤1+ at 30 days and 1 year, with TMVR showing a safety profile comparable to TEER and sustained improvements in symptoms and quality of life. For more content from TCT 2025 head to the Late-breaking Science Video Collection. Recorded on-site at TCT Conference in San Francisco, 2025. Editor: Mirjam Boros & Jordan Rance Video Specialist: Tom Green & Mike Knight Support: This is an independent interview produced by Transcatheter Academy. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook: / radcliffecardiology Follow us on X: https://x.com/radcliffeCARDIO